A pilot to assess target engagement of terazosin in Parkinson's disease-Reference-Cited by-同舟云学术

A pilot to assess target engagement of terazosin in Parkinson's disease

Published:2022-01 Issue: Volume:94 Page:79-83
ISSN:1353-8020
Container-title:Parkinsonism & Related Disorders
language:en
Short-container-title:Parkinsonism & Related Disorders

Author:

Schultz Jordan L.,Brinker Alivia N.,Xu Jia^ORCID,Ernst Sarah E.,Tayyari Fariba^ORCID,Rauckhorst Adam J.,Liu Lei^ORCID,Uc Ergun Y.^ORCID,Taylor Eric B.,Simmering Jacob E.,Magnotta Vincent A.^ORCID,Welsh Michael J.,Narayanan Nandakumar S.^ORCID

Funder

National Institutes of Health

Publisher

Elsevier BV

Subject

Neurology (clinical),Geriatrics and Gerontology,Neurology

Reference15 articles.

1. Mitochondria in the aetiology and pathogenesis of Parkinson's disease;Schapira;Lancet Neurol.,2008

2. Bioenergetics failure in neurodegenerative diseases: back to the future;Saxena;Expert Opin. Ther. Targets,2012

3. Brain glucose and energy metabolism during normal aging;Hoyer;Aging (Milano),1990

4. Mitochondrial complex I deficiency in Parkinson's disease;Schapira;Adv. Neurol.,1993

5. Classic and new animal models of Parkinson's disease;Blesa;J. Biomed. Biotechnol.,2012

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Exposure to Glycolysis-Enhancing Drugs and Risk of Parkinson’s Disease: A Meta-Analysis;Journal of Parkinson's Disease;2024-09-03

2. Association of Terazosin, Doxazosin, or Alfuzosin Use and Risk of Dementia With Lewy Bodies in Men;Neurology;2024-07-23

3. A pilot dose-finding study of Terazosin in humans;2024-05-22

4. Risk of Parkinson’s disease among users of alpha-adrenergic receptor antagonists: a systematic review and meta-analysis;Annals of Medicine & Surgery;2024-05-06

5. Terazosin attenuates abdominal aortic aneurysm formation by downregulating Peg3 expression to inhibit vascular smooth muscle cell apoptosis and senescence;European Journal of Pharmacology;2024-04